08:02pm Novo Nordisk Flags Unauthorized Access to 'Limited Number' of Internal IT Systems MT
07:54pm UK Regulator Approves Novo Nordisk's Weight-loss Pill MT
07:50pm Novo Nordisk Wins UK Approval for Wegovy Weight-Loss Pill MT
07:45pm Novo Nordisk's Wegovy Weight Loss Pill Approved in the U.K. DJ
07:45pm Novo Nordisk hit by cyber incident, probes data breach RE
07:40pm Novo Nordisk says security incident has access to limited internal IT systems RE
07:35pm Novo Nordisk Identifies IT Security Incident FW
07:32pm Novo Nordisk A/S: IT Security incident at Novo Nordisk GL
07:31pm Novo Nordisk A/S: IT Security incident at Novo Nordisk AQ
07:17pm Novo Nordisk's Wegovy Gets UK Approval for Obesity Treatment MT
07:16pm Novo Nordisk's Oral Wegovy Pill Receives Approval in the UK FW
07:04pm Novo Nordisk: Wegovy® pill (semaglutide tablets) becomes first daily GLP-1 weight-loss pill approved in the UK GL
07:03pm Novo Nordisk: Wegovy® pill (semaglutide tablets) becomes first daily GLP-1 weight-loss pill approved in the UK AQ
07:02pm UK health regulator approves Novo Nordisk's weight-loss pill RE
04:08pm The Secret Behind The Success Of WeGovy - Inside Novo Nordisk (Podcast) AQ
01:23pm SB1 maintains buy rating on Novo Nordisk following industry conference FW
06-10 Odin Norden gains 0.83 percent in May - BioMar spun off from Schouw FW
06-10 Novo Nordisk faces off in court with South African weight-loss drug compounder RE
06-09 NOVO NORDISK : Deutsche Bank reiterates its Neutral rating ZD
06-09 Novo Nordisk focuses on longevity and aesthetic medicine, going beyond weight loss AQ
06-09 NOVO NORDISK : JP Morgan sticks Neutral ZD
06-09 Health Care Ticks Down Amid Deal Activity - Health Care Roundup DJ
06-08 Novo Nordisk A/S - share repurchase programme GL
06-08 NOVO NORDISK : JP Morgan remains Neutral ZD
06-08 Novo Nordisk Weight-Loss Pill Prescriptions Hit Three Million Since Launch DJ
No results match your criteria
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!